These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11707316)

  • 21. Effects of ketanserin and DOI on spontaneous and 5-HT-evoked peristalsis of the pig ureter in vivo.
    Hauser DS; Mevissen M; Weiss R; Portier CJ; Scholtysik G; Studer UE; Danuser H
    Br J Pharmacol; 2002 Feb; 135(4):1026-32. PubMed ID: 11861331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profiles of R-96544, the active form of a novel 5-HT2A receptor antagonist R-102444.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Asai F
    Eur J Pharmacol; 2002 Dec; 457(2-3):107-14. PubMed ID: 12464356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of the serotonergic antagonist ketanserin.
    Stott DJ; Robertson JI; Ball SG
    J Hypertens Suppl; 1985 Dec; 3(3):S191-3. PubMed ID: 2856702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
    Banes AK; Watts SW
    Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by intraventricular microinfusion of ketanserin of the cardiovascular responses to peripheral administration of methoxamine in rats.
    Mollace V; De Francesco EA; Fersini G; Nisticò G
    Funct Neurol; 1991; 6(2):101-6. PubMed ID: 1655588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
    Docherty JR
    J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
    Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
    Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the mechanism of action of the hypotensive effect of ketanserin.
    Marwood JF; Stokes GS
    Clin Exp Pharmacol Physiol; 1984; 11(2):125-32. PubMed ID: 6086191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of alpha-adrenoceptor antagonism by the 5HT2 antagonist, ketanserin (R49945), in sheep.
    Nelson MA; Coghlan JP; Denton DA; Mills EH; Spence CD; Whitworth JA; Scoggins BA
    Clin Exp Pharmacol Physiol; 1984; 11(6):597-604. PubMed ID: 6152610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
    Scalbert E; Richer C; Giudicelli JF
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
    Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Hydroxytryptamine induces contraction in isolated human mammary artery: effect of ketanserin.
    Monopoli A; Conti A; Forlani A; Ongini E; Antona C; Biglioli P
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():59-61. PubMed ID: 2285652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.
    Saxena PR; Lawang A
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the chronic hypotensive mechanism of action of ketanserin in spontaneously hypertensive and Wistar-Kyoto rats.
    Balasubramaniam G; Lee HS; Mah SC
    J Hypertens; 1994 Jan; 12(1):7-14. PubMed ID: 8157947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does chronic ketanserin treatment enhance bradycardia in old rats by serotonergic blockade?
    Buñag RD; Davidow LW
    Aging (Milano); 1998 Apr; 10(2):102-11. PubMed ID: 9666190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical characterization of the mechanisms involved in the 5-hydroxytryptamine-induced increase in rat atrial rate.
    el Rawadi C; Davy M; Midol-Monnet M; Cohen Y
    Biochem Pharmacol; 1994 Aug; 48(4):683-8. PubMed ID: 7915903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus.
    Offord SJ; Warwick RO
    Eur J Pharmacol; 1984 Sep; 104(3-4):379-82. PubMed ID: 6499929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 5-hydroxytryptamine on human isolated placental chorionic arteries and veins.
    Reviriego J; Marín J
    Br J Pharmacol; 1989 Apr; 96(4):961-9. PubMed ID: 2743086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.